Cargando…
Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
Background: Left ventricular assist device (LVAD) therapy has improved the clinical outcomes in advanced heart failure patients, however, this may differ between countries. We aimed to compare outcomes between Japanese and US LVAD cohorts. Methods: For 416 consecutive LVAD patients who received Hear...
Autores principales: | Imamura, Teruhiko, Ono, Minoru, Kinugawa, Koichiro, Fukushima, Norihide, Shiose, Akira, Matsui, Yoshiro, Yamazaki, Kenji, Saiki, Yoshikatsu, Usui, Akihiko, Niinami, Hiroshi, Matsumiya, Goro, Arai, Hirokuni, Sawa, Yoshiki, Uriel, Nir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142632/ https://www.ncbi.nlm.nih.gov/pubmed/32183082 http://dx.doi.org/10.3390/medicina56030126 |
Ejemplares similares
-
Can the intermittent low-speed function of left ventricular assist device prevent aortic insufficiency?
por: Kohno, Hiroki, et al.
Publicado: (2021) -
Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023) -
Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
por: Imamura, Teruhiko, et al.
Publicado: (2020) -
Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021) -
Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
por: Hayashi, Hideyuki, et al.
Publicado: (2021)